Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Deferred Taxes (2021 - 2025)

Rxo (RXO) has disclosed Deferred Taxes for 5 consecutive years, with -$6.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 14.29% year-over-year to -$6.0 million, compared with a TTM value of -$21.0 million through Dec 2025, down 10.53%, and an annual FY2025 reading of -$21.0 million, down 10.53% over the prior year.
  • Deferred Taxes was -$6.0 million for Q4 2025 at Rxo, down from -$2.0 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $2.0 million in Q4 2021 and bottomed at -$12.0 million in Q4 2022.
  • Average Deferred Taxes over 5 years is -$4.6 million, with a median of -$4.5 million recorded in 2023.
  • The sharpest move saw Deferred Taxes crashed 700.0% in 2022, then surged 57.14% in 2023.
  • Year by year, Deferred Taxes stood at $2.0 million in 2021, then plummeted by 700.0% to -$12.0 million in 2022, then skyrocketed by 41.67% to -$7.0 million in 2023, then changed by 0.0% to -$7.0 million in 2024, then grew by 14.29% to -$6.0 million in 2025.
  • Business Quant data shows Deferred Taxes for RXO at -$6.0 million in Q4 2025, -$2.0 million in Q3 2025, and -$2.0 million in Q2 2025.